Results 121 to 130 of about 552 (131)

Safety and pharmacokinetics of olokizumab, an anti‐IL‐6 monoclonal antibody, administered to healthy male volunteers: A randomized phase I study

Clinical Pharmacology in Drug Development, 2014
Georg Golor
exaly  

The efficiency of different olokizumab dosage regimens in patients with mild and moderate coronavirus disease (COVID-19)

Èpidemiologiâ i Infekcionnye Bolezni. Aktual’nye voprosy, 2023
Ignatyev V.G. Ignatyev, Samsonov M.Yu. Samsonov, Khanonina E.K. Khanonina, Dokukina E.A. Dokukina, Petkova A.V. Petkova, Filon O.V. Filon, Mozgovaya V.G. Mozgovaya V, Vorobyev A.S. Vorobyev, Simakova A.I. Simakova, Kuncevich E.V. Kuncevich, Bakhtina V.A. Bakhtina, Mukha T.A. Mukha, Demko I.V. Demko, Soldatov V.M. Soldatov, Rechnik V.N. Rechnik V, Ostroverkhov O.P. Ostroverkhov, Ignatova G.L. Ignatova, Kostina N.E. Kostina N, Lesina V.S. Lesina, Tavlueva E.V. Tavlueva, Agafyina A.S. Agafyina, Bakirov B.A. Bakirov   +21 more
openaire   +1 more source

Probing binding mechanism of interleukin-6 and olokizumab: in silico design of potential lead antibodies for autoimmune and inflammatory diseases

Journal of Receptor and Signal Transduction Research, 2016
Rashi Verma, Dibyabhaba Pradhan, Rajabrata Bhuyan   +2 more
exaly  

Olokizumab

Reactions Weekly
openaire   +1 more source

Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial

Modern Rheumatology, 2016
Tsutomu Takeuchi, Yoshiya Tanaka, Hisashi Yamanaka   +2 more
exaly  

ASSOCIATIONS BETWEEN miRNA EXPRESSION IN RUSSIAN PATIENTS WITH RHEUMATOID ARTHRITIS AND EFFICIENCY OF OLOKIZUMAB TREATMENT

Сборник материалов, 2020
I. Bure, D.S. Mikhaylenko, E. Kuznetsova, E. Alekseeva, K.V. Bondareva, M.V. Nemtsova   +5 more
openaire   +1 more source

Olokizumab Treatment of both Western and Asian Patients with Rheumatoid Arthritis who have Failed Anti-Tnf Treatment Results in Sustained Improvements in Patient-Reported Outcomes

Value in Health, 2016
P Durez, De Fürst
exaly  

Detection of Free and Olokizumab-Bound Interleukin-6 during Anticytokine Therapy

Biochemistry (Moscow)
Aleksandra V. Pavlova, Anna M. Litvinova, Ekaterina O. Gubernatorova, Anastasia S. Yakovleva, Sergei A. Nedospasov, Marina S. Drutskaya, Irina V. Astrakhantseva   +6 more
openaire   +1 more source

POS0646 EFFECT OF OLOKIZUMAB ON THE NEUTROPHIL-LYMPOCYTE RATIO IN PATIENTS WITH RHEUMATOID ARTHRITIS

Annals of the Rheumatic Diseases
E. Feist, A. Egorova, E. Alekseev
openaire   +1 more source

Efficacy of Olokizumab against Comorbid Depressive Disorder in Patients with Rheumatoid Arthritis: Preliminary Results of the Study

Doklady Biochemistry and Biophysics
T A Lisitsyna, E L Nasonov, Nasonov E L
exaly